C. Daniel Mullins, PhD, is a professor in the Pharmaceutical Health Services Research Department (PHSR) at the University of Maryland School of Pharmacy. Professor Mullins’ research and teaching focus on pharmacoeconomics, comparative effectiveness research, patient-centered outcomes research, and health disparities research. He has received funding as a Principal Investigator from the Agency for Healthcare Research and Quality (AHRQ), National Institute on Aging (NIA), the National Heart, Lung, and Blood Institute (NHLBI), the Patient-Centered Outcomes Research Institute (PCORI), various pharmaceutical manufacturers including Bayer, Pfizer and Sanofi-Aventis, patent advocacy organizations, and the insurance industry. In addition to his faculty appointment, Professor Mullins also serves as the Associate Director of the Center on Drugs and Public Policy at the School of Pharmacy, as well as the Co-Editor-in-Chief for Value in Health. Professor Mullins received his BS in Economics from M.I.T. and his PhD in Economics from Duke University.